Canadian mega-producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) posted positive results that illustrate the company’s efficiency amid a crowded supply side market and pinching margins. The Québec-based operator released its fourth quarter and fiscal year 2022 financial results for the three-month and full year periods ending August 31. Cannara reported C$12 million in revenue, an […]